- The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report
-
Yim GW, Suh DH, Kim JW, Kim SC, Kim YT
- KMID: 2450248
- J Gynecol Oncol.
- 2019 Jul;30(4):e91.
- doi: 10.3802/jgo.2019.30.e91
The 34th Annual Meeting of Korean Society of Gynecologic Oncology (KSGO) was held in Busan, Korea from 26 to 27 April. Around 460 Korean and international clinicians gathered in Busan... -
- CITED
-
- Close
- SHARE
-
- Close
- Adjuvant chemotherapy in locally advanced cervical cancer: the ceiling remains unbroken
-
Gupta S
- KMID: 2450249
- J Gynecol Oncol.
- 2019 Jul;30(4):e97.
- doi: 10.3802/jgo.2019.30.e97
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical significance of variants of unknown significances in BRCA genes
-
Choi MC
- KMID: 2450245
- J Gynecol Oncol.
- 2019 Jul;30(4):e80.
- doi: 10.3802/jgo.2019.30.e80
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The influence of BRCA variants of unknown significance on cancer risk management decision-making
-
Chern JY, Lee SS, Frey MK, Lee J, Blank SV
- KMID: 2450239
- J Gynecol Oncol.
- 2019 Jul;30(4):e60.
- doi: 10.3802/jgo.2019.30.e60
OBJECTIVE: To compare gynecological cancer risk management between women with BRCA variants of unknown significance (VUS) to women with negative genetic testing METHODS: Ninety-nine patients whose BRCA genetic testing yielded VUS... -
- CITED
-
- Close
- SHARE
-
- Close
- Actinomycin D shortage in the Brazilian market: new challenges for successful treatment of gestational trophoblastic neoplasia
-
Paulino E, de Melo AC
- KMID: 2450247
- J Gynecol Oncol.
- 2019 Jul;30(4):e87.
- doi: 10.3802/jgo.2019.30.e87
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia
-
Chen X
- KMID: 2450244
- J Gynecol Oncol.
- 2019 Jul;30(4):e79.
- doi: 10.3802/jgo.2019.30.e79
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes
-
Şahin H, Karatas F, Coban G, Özen O, Erdem O, Onan MA, Ayhan A
- KMID: 2450233
- J Gynecol Oncol.
- 2019 Jul;30(4):e54.
- doi: 10.3802/jgo.2019.30.e54
OBJECTIVE: In this study, we aimed to evaluate the clinicopathological features, obstetric, and oncological outcomes of patients diagnosed with a uterine smooth muscle tumors of uncertain malignant potential (STUMP). METHODS: A... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical comparison between neuroendocrine and endometrioid type carcinoma of the uterine corpus
-
Mei S, Gibbs J, Economos K, Lee YC, Kanis MJ
- KMID: 2450237
- J Gynecol Oncol.
- 2019 Jul;30(4):e58.
- doi: 10.3802/jgo.2019.30.e58
OBJECTIVE: To compare the clinicopathologic features and survival outcomes of neuroendocrine tumor of the uterine corpus (NET-U) to endometrioid type endometrial carcinoma (EC). METHODS: From 1993 to 2012, the Surveillance, Epidemiology... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study
-
Petrillo M, Zucchetti , Cianci S, Morosi L, Ronsini C, Colombo A, D'Incalci , Scambia G, Fagotti A
- KMID: 2450238
- J Gynecol Oncol.
- 2019 Jul;30(4):e59.
- doi: 10.3802/jgo.2019.30.e59
OBJECTIVE: Evidences from animal models seem to suggest that minimally invasive surgery may enhance cisplatin diffusion when the drug is administered in the context of post-operative hyperthermic intraperitoneal chemotherapy (HIPEC).... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study
-
Leone Roberti Maggiore U, Martinelli F, Dondi G, Bogani G, Chiappa V, Evangelista MT, Liberale V, Ditto A, Ferrero S, Raspagliesi F
- KMID: 2450236
- J Gynecol Oncol.
- 2019 Jul;30(4):e57.
- doi: 10.3802/jgo.2019.30.e57
OBJECTIVE: To investigate the efficacy of levonorgestrel-releasing intra-uterine system (LNG-IUS) treatment in patients affected by atypical complex hyperplasia/endometrial cancer (ACH/EC) wishing to preserve their fertility and to present fertility outcomes... -
- CITED
-
- Close
- SHARE
-
- Close
- A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial
-
Tangjitgamol S, Tharavichitkul E, Tovanabutra C, Rongsriyam K, Asakij T, Paengchit , Sukhaboon , Penpattanagul S, Kridakara , Hanprasertpong J, Chomprasert K, Wanglikitkoon S, Atjimakul , Pariyawateekul P, Katanyoo K, Tanprasert P, Janweerachai W, Sangthawan D, Khunnarong J, Chottetanaprasith T, Supawattanabodee B, Lertsanguansinchai P, Srisomboon J, Isaranuwatchai W, Lorvidhaya V
- KMID: 2450246
- J Gynecol Oncol.
- 2019 Jul;30(4):e82.
- doi: 10.3802/jgo.2019.30.e82
OBJECTIVE: To compare response rate and survivals of locally advanced stage cervical cancer patients who had standard concurrent chemoradiation therapy (CCRT) alone to those who had adjuvant chemotherapy (ACT) after... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
-
Reboux PA, Azaïs H, Canova CH, Bendifallah S, Ouldamer L, Raimond E, Hudry D, Coutant C, Graesslin , Touboul C, Collinet P, Bricou A, Huchon C, Daraï E, Ballester , Lévêque , Lavoué V, Koskas M, Uzan C, Canlorbe G
- KMID: 2450232
- J Gynecol Oncol.
- 2019 Jul;30(4):e53.
- doi: 10.3802/jgo.2019.30.e53
OBJECTIVE: According to recent European Society of Medical Oncology, European Society of Gynaecological Oncology and European Society of Radiotherapy and Oncology guidelines, adjuvant vaginal brachytherapy (VB) is optional in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancer
-
Normann MC, Türzer M, Diep LM, Oldenburg , Gajdzik B, Solheim O, Rud E
- KMID: 2450235
- J Gynecol Oncol.
- 2019 Jul;30(4):e56.
- doi: 10.3802/jgo.2019.30.e56
OBJECTIVE: In this study, we evaluated the toxicity and clinical efficacy of nivolumab, a programmed cell death protein 1 (PD-1) inhibitor, on patients with platinum resistant ovarian cancer. METHODS: Every second... -
- CITED
-
- Close
- SHARE
-
- Close
- Conservative hysteroscopic treatment of stage I well differentiated endometrial cancer in patients with high surgical risk: a pilot study
-
Casadio P, Guasina F, Talamo MR, Paradisi R, Morra C, Magnarelli G, Seracchioli R
- KMID: 2450241
- J Gynecol Oncol.
- 2019 Jul;30(4):e62.
- doi: 10.3802/jgo.2019.30.e62
OBJECTIVE: To report hysteroscopic treatment combined with levonorgestrel-releasing intrauterine device (LNG-IUD) to treat women with early well differentiated endometrial cancer (EC) at high surgical risk. METHODS: Nine women diagnosed with stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer
-
Ñiguez Sevilla I, Machado Linde F, MarÃn Sánchez MdP, Arense JJ, Torroba A, Nieto DÃaz A, Sánchez Ferrer ML
- KMID: 2450242
- J Gynecol Oncol.
- 2019 Jul;30(4):e63.
- doi: 10.3802/jgo.2019.30.e63
OBJECTIVE: Patients with endometriosis are at increased risk of ovarian cancer. It has been suggested that atypical endometriosis is a precursor lesion of endometriosis-associated ovarian cancer (EAOC). The aim of... -
- CITED
-
- Close
- SHARE
-
- Close
- Stage and histology of cervical cancer in women under 25 years old
-
Vale DB, Cavalcante LA, Andrade LA, Teixeira J, Menin TL, Zeferino L
- KMID: 2450234
- J Gynecol Oncol.
- 2019 Jul;30(4):e55.
- doi: 10.3802/jgo.2019.30.e55
OBJECTIVE: To evaluate the histological and stage characteristics of cervical cancer in women under 25 years old, and to compare them with older women. METHODS: Cross-sectional study of cases from the... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database
-
Cho HW, Ouh YT, Lee JK, Hong JH
- KMID: 2450230
- J Gynecol Oncol.
- 2019 Jul;30(4):e51.
- doi: 10.3802/jgo.2019.30.e51
OBJECTIVE: The aim of this study was to verify the effects of hormone therapy (HT) on recurrence in endometrial cancer (EC) survivors using the Korean Health Insurance Review and Assessment... -
- CITED
-
- Close
- SHARE
-
- Close
- A pilot study of gonadotropin-releasing hormone agonist combined with aromatase inhibitor as fertility-sparing treatment in obese patients with endometrial cancer
-
Zhang Z, Huang H, Feng F, Wang J, Cheng N
- KMID: 2450240
- J Gynecol Oncol.
- 2019 Jul;30(4):e61.
- doi: 10.3802/jgo.2019.30.e61
OBJECTIVE: This study aims to evaluate the effects and pregnancy outcomes of gonadotropin-releasing hormone agonist (GnRH agonist) combined with aromatase inhibitor (AI) in preserving the fertility of obese women with... -
- CITED
-
- Close
- SHARE
-
- Close
- Human papillomavirus genotype-specific risk in cervical carcinogenesis
-
So KA, Lee IH, Lee KH, Hong SR, Kim YJ, Seo HH, Kim TJ
- KMID: 2450231
- J Gynecol Oncol.
- 2019 Jul;30(4):e52.
- doi: 10.3802/jgo.2019.30.e52
OBJECTIVE: To evaluate the risk of genotype-specific human papillomavirus (HPV) infections for the spectrum of cervical carcinogenesis and the distribution of HPV types according to age and different cervical lesions METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods
-
Paik ES, Lee JW, Park JY, Kim JH, Kim M, Kim TJ, Choi CH, Kim BG, Bae DS, Seo SW
- KMID: 2450243
- J Gynecol Oncol.
- 2019 Jul;30(4):e65.
- doi: 10.3802/jgo.2019.30.e65
OBJECTIVES: The aim of this study was to develop a new prognostic classification for epithelial ovarian cancer (EOC) patients using gradient boosting (GB) and to compare the accuracy of the... -
- CITED
-
- Close
- SHARE
-
- Close
